http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20100032029-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_239beeed9eb874437e6d56d61c56f475 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-539 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-539 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 |
| filingDate | 2008-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428dafbb868d4483b03d768cd6793fba http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b6ef3b3b078784dfcdb690663b8a917 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b50edf0048fd48e1f56230f8e94d4d4c |
| publicationDate | 2010-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20100032029-A |
| titleOfInvention | Composition for the treatment of attention deficit hyperactivity disorder |
| abstract | The present invention provides a pharmaceutical composition for treating attention deficit and hyperactivity disorder containing golden extract as an active ingredient. The pharmaceutical composition of the present invention can be used as a symptomatic therapy for ADHD because it improves concentration while suppressing hyperactivity, and solves psychosocial disorders including children's learning disabilities, and may cause long-term anticipation of adolescent delinquency or deviant behavior. In adulthood, drug abuse and crime can be prevented. |
| priorityDate | 2008-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 36.